PLAN ESTRATÉGICO DE INVESTIGACIÓN
LÍNEAS DE INVESTIGACIÓN
PROYECTOS DE INVESTIGACIÓN
ENSAYOS CLÍNICOS
GRUPOS COOPERATIVOS
COMUNICACIONES A CONGRESOS
PUBLICACIONES
BECAS Y RECURSOS
INVESTIGACIÓN EN OTROS LUGARES
BIBLIOGRAFIA
NUESTROS RESULTADOS

PUBLICACIONES > Año 2011

Leukemia. 2011 Jan;25(1):75-81. Epub 2010 Sep 30.

Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT. Robin M, Sanz GF, Ionescu I, Rio B, Sirvent A, Renaud M, Carreras E, Milpied N, Mohty M, Beguin Y, Bordigoni P, de Witte T, Picardi A, Purtill D, Gluckman E, Kroger N, Rocha V.

 

Blood. 2011 Feb 10;117(6):1799-805. Epub 2010 Dec 8.

Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens. Montesinos P, Rayón C, Vellenga E, Brunet S, González J, González M, Holowiecka A, Esteve J, Bergua J, González JD, Rivas C, Tormo M, Rubio V, Bueno J, Manso F, Milone G, de la Serna J, Pérez I, Pérez-Encinas M, Krsnik I, Ribera JM, Escoda L, Lowenberg B, Sanz MA; PETHEMA; HOVON Groups.

 

Haematologica. 2011 Jan;96(1):156-62. Epub 2010 Nov 3.

The European LeukemiaNet: achievements and perspectives. Hehlmann R, Grimwade D, Simonsson B, Apperley J, Baccarani M, Barbui T, Barosi G, Bassan R, Béné MC, Berger U, Büchner T, Burnett A, Cross NC, de Witte TJ, Döhner H, Dombret H, Einsele H, Engelich G, Foà R, Fonatsch C, Gökbuget N, Gluckman E, Gratwohl A, Guilhot F, Haferlach C, Haferlach T, Hallek M, Hasford J, Hochhaus A, Hoelzer D, Kiladjian JJ, Labar B, Ljungman P, Mansmann U, Niederwieser D, Ossenkoppele G, Ribera JM, Rieder H, Serve H, Schrotz-King P, Sanz MA, Saussele S; European LeukemiaNet.

 

Blood. 2011 Jan 6;117(1):242-5. Epub 2010 Oct 8.

A novel NUP98/RARG gene fusion in acute myeloid leukemia resembling acute promyelocytic leukemia. Such E, Cervera J, Valencia A, Barragán E, Ibañez M, Luna I, Fuster O, Perez-Sirvent ML, Senent L, Sempere A, Martinez J, Martín-Aragonés G, Sanz MA.

 

Value Health. 2011 Jan;14(1):90-6.

Analysis of EQ-5D scores from two phase 3 clinical trials of romiplostim in the treatment of immune thrombocytopenia (ITP). Sanz MA, Aledort L, Mathias SD, Wang X, Isitt JJ.

 

J Clin Oncol. 2011 Feb 10;29(5):495-503. Epub 2011 Jan 10.

Modern approaches to treating acute promyelocytic leukemia. Sanz MA, Lo-Coco F.

 

Haematologica. 2011 Mar;96(3):375-83. Epub 2010 Nov 25.

Cytogenetic risk stratification in chronic myelomonocytic leukemia. Such E, Cervera J, Costa D, Solé F, Vallespí T, Luño E, Collado R, Calasanz MJ, Hernández-Rivas JM, Cigudosa JC, Nomdedeu B, Mallo M, Carbonell F, Bueno J, Ardanaz MT, Ramos F, Tormo M, Sancho-Tello R, Cañizo CD, Gómez V, Marco V, Xicoy B, Bonanad S, Pedro C, Bernal T, Sanz GF.

 

Biol Blood Marrow Transplant. 2011 Jan;17(1):78-85. Epub 2010 Jun 16.

Influence of nucleated cell dose on overall survival of unrelated cord blood transplantation for patients with severe acquired aplastic anemia: a study by eurocord and the aplastic anemia working party of the European group for blood and marrow transplantation. Peffault de Latour R, Purtill D, Ruggeri A, Sanz G, Michel G, Gandemer V, Maury S, Kurtzberg J, Bonfim C, Aljurf M, Gluckman E, Socié G, Passweg J, Rocha V.

 

Leukemia. 2011 Jan;25(1):110-20. Epub 2010 Sep 30.

Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q. Mallo M, Cervera J, Schanz J, Such E, García-Manero G, Luño E, Steidl C, Espinet B, Vallespí T, Germing U, Blum S, Ohyashiki K, Grau J, Pfeilstöcker M, Hernández JM, Noesslinger T, Giagounidis A, Aul C, Calasanz MJ, Martín ML, Valent P, Collado R, Haferlach C, Fonatsch C, Lübbert M, Stauder R, Hildebrandt B, Krieger O, Pedro C, Arenillas L, Sanz MÁ, Valencia A, Florensa L, Sanz GF, Haase D, Solé F.

 

Leuk Lymphoma. 2011 Jan;52(1):9-14. Epub 2010 Nov 15.

Treatment of multiple myeloma in the elderly: realities and hopes. De La Rubia J, Sanz MA.

 

Practice Research and  Innovation

Eculizumab in paroxysmal nocturnal haemoglobinuria. Angel Escudero-Jimenez, PharmD; María Jesus Esteban-Mensua, PhD; Eduardo Lopez-Briz, PharmD; Isidro Jarque-Ramos, MD, PhD; Carmela Borrell-García, PharmD; José Luis Poveda-Andres, PhD

 

Leuk Res. 2011 Apr;35(4):479-83. Epub 2010 Sep 22.

Aberrant methylation of tumor suppressor genes in patients with refractory anemia with ring sideroblasts. Valencia A, Cervera J, Such E, Ibañez M, Gómez I, Luna I, Senent L, Oltra S, Sanz MA, Sanz GF.

  

Bone Marrow Transplant. 2011 Jan;46(1):52-8. Epub 2010 Mar 22.

Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data. Duarte RF, Shaw BE, Marín P, Kottaridis P, Ortiz M, Morante C, Delgado J, Gayoso J, Goterriz R, Martínez-Chamorro C, Mateos-Mazón JJ, Ramírez C, de la Rubia J, Achtereekte H, Gandhi PJ, Douglas KW, Russell NH.

 

Antivir Ther. 2011;16(7):951-7.

Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients. Ruiz-Camps I, Len O, de la Cámara R, Gurguí M, Martino R, Jarque I, Barrenetxea C, Díaz de Heredia C, Batlle M, Rovira M, de la Torre J, Torres A, Aguilar M, Espigado I, Martín-Dávila P, Bou G, Borrell N, Aguado JM, Pahissa A; Spanish Network for Research on Infection in Transplantation (RESITRA/REIPI). Spain.

PMID: 22024510

 

Biol Blood Marrow Transplant. 2011 Nov 8. [Epub ahead of print]

Significance of increased blastic-appearing cells in bone marrow following myeloablative unrelated cord blood transplantation in adult patients. Montesinos P, Gascón A, Martínez-Cuadrón D, Senent ML, Cordón L, Sanz J, Sempere A, López-Pavía M, Rodríguez-Veiga R, Hurtado MJ, Gomis F, Martín G, Lorenzo I, Palau J, Planelles MD, Larrea L, Carpio N, Pérez-Sirvent M, Sanz MA, Sanz GF.                                                                                          

PMID: 22079468 

 

Haematologica. 2011 Nov 4. [Epub ahead of print]

Benefit from autologous stem cell transplantation in primary refractory myeloma? Different outcomes in progressive versus stable disease Rosinol L, Garcia-Sanz R, Lahuerta JJ, Hernandez M, Granell M, de la Rubia J, Oriol A, Hernandez B, Rayon C, Navarro I, Garcia-Ruiz JC, Besalduch J, Gardella S, Lopez J, Diaz-Mediavilla J, Alegre A, San Miguel J, Blade' J.

PMID:22058223

 

 Ann Hematol. 2011 Sep 21. [Epub ahead of print]

Prognostic value of cytogenetics in adult patients with Philadelphia-negative acute lymphoblastic leukemia. Gómez-Seguí I, Cervera J, Such E, Martínez-Cuadrón D, Luna I, Ibáñez M, López-Pavía M, Gascón A, Roig M, Martínez J, Sanz J, Montesinos P, Martín-Aragonés G, Lorenzo I, Senent L, Barragán E, Cordón L, Sempere A, Sanz GF, Sanz MA. PMID: 21935650

 

JAMA. 2011 Aug 10;306(6):610; author reply 610-1. No abstract available.

Whole-genome sequencing and acute promyelocytic leukemia. Lo-Coco F, Sanz MA.

PMID: 21828321

 

Leuk Res. 2011 Jul 2. [Epub ahead of print]

Functional polymorphisms in SOCS1 and PTPN22 genes correlate with the response to imatinib treatment in newly diagnosed chronic-phase chronic myeloid leukemia Guillem V, Amat P, Cervantes F, Alvarez-Larrán A, Cervera J, Maffioli M, Bellosillo B, Collado M, Marugán I, Martínez-Ruiz F, Hernández-Boluda JC.

PMID: 21724255

 

 

Haematologica. 2011 Oct;96(10):1448-56. Epub 2011 Jul 12.

Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia Vazquez I, Maicas M, Cervera J, Agirre X, Marin-Bejar O, Marcotegui N, Vicente C, Lahortiga I, Gomez-Benito M, Carranza C, Valencia A, Brunet S, Lumbreras E, Prosper F, Gomez-Casares MT, Hernandez-Rivas JM, Calasanz MJ, Sanz MA, Sierra J, Odero MD.

PMID: 21750091

 

Blood. 2011 Jul 13. [Epub ahead of print]

A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q. Fenaux P, Giagounidis A, Selleslag D, Beyne-Rauzy O, Mufti G, Mittelman M, Muus P, Te Boekhorst P, Sanz G, Del Cañizo C, Guerci-Bresler A, Nilsson L, Platzbecker U, Lübbert M, Quesnel B, Cazzola M, Ganser A, Bowen D Dr, Schlegelberger B, Aul C, Knight R, Francis J, Fu T, Hellström-Lindberg E.

PMID: 21753188

 

Haematologica. 2011 Oct;96(10):1470-7. Epub 2011 Jun 17.

Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy Barragan E, Montesinos P, Camos M, Gonzalez M, Calasanz MJ, Roman-Gomez J, Gomez-Casares MT, Ayala R, Lopez J, Fuster O, Colomer D, Chillon C, Larrayoz MJ, Sanchez-Godoy P, Gonzalez-Campos J, Manso F, Amador ML, Vellenga E, Lowenberg B, Sanz MA.

PMID: 21685470

 

Blood. 2011 Jul 21;118(3):529-34. Epub 2011 Apr 11.

Long-term prognostic significance of response in multiple myeloma after stem cell transplantation Martinez-Lopez J, Blade J, Mateos MV, Grande C, Alegre A, García-Laraña J, Sureda A, de la Rubia J, Conde E, Martinez R, de Arriba F, Viguria MC, Besalduch J, Cabrera R, Gonzalez-San Miguel JD, Guzman-Zamudio JL, Gomez del Castillo MC, Moraleda JM, García-Ruiz JC, San Miguel J, Lahuerta JJ; Grupo Español de MM; Programa para el Estudio de la Terapé utica en Hemopatía Maligna.

PMID:21482708

 

Biol Blood Marrow Transplant. 2011 Jun 12.

Donor CTLA-4 Genotype Influences Clinical Outcome after T Cell-Depleted Allogeneic Hematopoietic Stem Cell Transplantation from HLA-Identical Sibling Donors. Bosch-Vizcaya A, Pérez-García A, Brunet S, Solano C, Buño I, Guillem V, Martínez-Laperche C, Sanz G, Barrenetxea C, Martínez C, Tuset E, Lloveras N, Coll R, Guardia R, González Y, Roncero JM, Bustins A, Gardella S, Fernández C, Buch J, Gallardo D; on behalf of the GvHD/Immunotherapy committee of the Spanish Group for Hematopoietic Transplant (GETH)

PMID: 21703972

 

Enferm Infecc Microbiol Clin. 2011 Mar;29 Suppl 2:43-9. Review. Spanish.

Is micafungin useful in the prophylaxis of invasive fungal disease in hematological patients?.Salavert M, Jarque I.

PMID: 21420577

 

Haematologica. 2011 Mar;96(3):375-83. Epub 2010 Nov 25.

Cytogenetic risk stratification in chronic myelomonocytic leukemia.Such E, Cervera J, Costa D, Solé F, Vallespí T, Luño E, Collado R, Calasanz MJ, Hernández-Rivas JM, Cigudosa JC, Nomdedeu B, Mallo M, Carbonell F, Bueno J, Ardanaz MT, Ramos F, Tormo M, Sancho-Tello R, del Cañizo C, Gómez V, Marco V, Xicoy B, Bonanad S, Pedro C, Bernal T, Sanz GF.

PMID: 21109693

Expert Rev Hematol. 2011 Feb;4(1):9-16.

 

Incidence of cytomegalovirus infection and disease in patients with lymphoproliferative disorders treated with alemtuzumab.Vallejo C, Ríos E, de la Serna J, Jarque I, Ferrá C, Sánchez-Godoy P, Solano C, de la Cámara R, Rosell AI, Varela R, García MD, González-Barca E, López J, Pérez E, Ferrer S, Casado LF, Vázquez L, Villalón L, García-Marco JA.

PMID:21322774

Secretaría del Servicio de Hematología · Hospital General, Planta Baja · Hospital Universitario La Fe · Avda. Campanar 21 · 46021 Valencia. · Tfno.:963 862 745 · Fax: 961 973 281
Aviso legal · Mapa web
[X] Cerrar